Global Amyotrophic Lateral Sclerosis Treatment Market 2019-2023 - Industry Analysis and Forecast - Technavio
LONDON--(BUSINESS WIRE)--Jan 9, 2019-- analysts forecast the global amyotrophic lateral sclerosis treatment market to grow at a CAGR of approximately 20% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190109005303/en/
Technavio forecasts the global amyotrophic lateral sclerosis treatment market to grow at a CAGR of approximately 20%by 2023. (Photo: Business Wire)
The development of novel approaches for the treatment of amyotrophic lateral sclerosis is one of the major trends being witnessed in the . That market has been witnessing a rise in the development of new drugs therapies that are disease-modifying drugs. Owing to the increase in the prevalence of amyotrophic lateral sclerosis across the globe, researchers are focused on developing disease-modifying therapies for the treatment of amyotrophic lateral sclerosis.
According to Technavio analysts, one of the key factors contributing to the growth of global amyotrophic lateral sclerosis treatment market is the increase in incidence and prevalence of ALS:
Global amyotrophic lateral sclerosis treatment market: Increase in incidence and prevalence of ALS
The incidence and prevalence of amyotrophic lateral sclerosis have been increasing. The prevalence of amyotrophic lateral sclerosis in the US was estimated to be 3.9 cases of amyotrophic lateral sclerosis per 100,000 people during 2010-2011. In 2014, the prevalence of amyotrophic lateral sclerosis was 5.0 cases per 100,000 persons in the US. Amyotrophic lateral sclerosis was more common among white men, non-Hispanics, and individuals between aged 60-69 years in the US.
According to a senior research analyst at Technavio, “Dietary exposure to cyanotoxin BMAA that is a non-proteinogenic amino acid beta-Methylamino-L-alanine produced by cyanobacteria in marine and freshwater could be the cause for amyotrophic lateral sclerosis. Thus, owing to the increase in prevalence and incidence of amyotrophic lateral sclerosis, the market is expected to witness an accelerated growth during the forecast period.”
Global amyotrophic lateral sclerosis treatment market: Segmentation analysis
The global amyotrophic lateral sclerosis treatment market research report provides market segmentation by type (intravenous and oral) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The intravenous segment held the largest amyotrophic lateral sclerosis treatment market share in 2018, accounting for around 84% of the market. This segment is expected to dominate the global market throughout the forecast period.
The Americas held the largest share of the market in 2018, accounting for more than 45% share. It was followed by EMEA and APAC respectively. The Americas is expected to dominate the market throughout the period 2019-2023.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005303/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: PROFESSIONAL SERVICES CONSULTING
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 01/09/2019 10:01 AM/DISC: 01/09/2019 10:02 AM